In skeletal muscle cells, voltage-dependent potentiation of Ca 2؉ channel activity requires phosphorylation by cAMP-dependent protein kinase (PKA) anchored via an A-kinase anchoring protein (AKAP15), and the most rapid sites of phosphorylation are located in the C-terminal domain. Surprisingly, the site of interaction of the complex of PKA and AKAP15 with the ␣1-subunit of CaV1.1 channels lies in the distal C terminus, which is cleaved from the remainder of the channel by in vivo proteolytic processing. Here we report that the distal C terminus is noncovalently associated with the remainder of the channel via an interaction with a site in the proximal C-terminal domain when expressed as a separate protein in mammalian nonmuscle cells. Deletion mapping of the C terminus of the ␣1-subunit using the yeast two-hybrid assay revealed that a distal C-terminal peptide containing amino acids 1802-1841 specifically interacts with a region in the proximal C terminus containing amino acid residues 1556 -1612. Analysis of the purified ␣1-subunit of CaV1.1 channels from skeletal muscle by saturation sequencing of the intracellular peptides by tandem mass spectrometry identified the site of proteolytic processing as alanine 1664. Our results support the conclusion that a noncovalently associated complex of the ␣1-subunit truncated at A1664 with the proteolytically cleaved distal C-terminal domain, AKAP15, and PKA is the primary physiological form of CaV1.1 channels in skeletal muscle cells.
I
n skeletal muscle, voltage-gated Ca 2ϩ channels localized in the transverse tubule membrane play a pivotal role in excitationcontraction (E-C) coupling (1) . After membrane depolarization during an action potential, these Ca 2ϩ channels function as voltage sensors to initiate E-C coupling and as a slowly activating Ca 2ϩ entry pathway that regulates contractile force (2, 3) . Trains of high-frequency depolarizing stimuli that mimic action potentials or single long depolarizing pulses greatly increase the activity of these Ca 2ϩ channels (4, 5) . This ''potentiation'' of Ca 2ϩ channel activity is strongly voltage-dependent and, in skeletal muscle, requires phosphorylation by cAMP-dependent protein kinase (PKA) anchored via an AKAP (AKAP15; refs. 4 and 6-8) .
The molecular mechanism underlying the targeting of PKA to the Ca V 1 family of Ca 2ϩ channels has recently emerged. AKAP15 directly targets PKA to the distal C terminus of cardiac and skeletal muscle Ca V 1 channels through a modified leucine zipper interaction (9, 10) . Mutation of this motif prevents PKA anchoring, and disruption of this interaction with dominantnegative peptides prevents PKA-dependent potentiation of Ca 2ϩ channel activity in skeletal and cardiac myocytes (9, 10) . Thus, anchoring of PKA to Ca V 1.1 channels via AKAP15 favors rapid phosphorylation and modulation of these channels as part of the overall regulation of contractile force in response to motor nerve stimulation (11, 12) .
Two size forms of the ␣ 1 -subunit of Ca V 1.1 channels, Ϸ175 and 212 kDa, exist in membrane preparations from skeletal muscle (13) (14) (15) (16) . The predominant (Ͼ90%) short form results from in vivo proteolytic processing of the C terminus near amino acid residue 1685, approximately halfway through the C-terminal domain (14) . Similarly, the related Ca V 1.2 channels in heart and brain are also truncated by in vivo proteolysis at a similar position in their C termini (17) (18) (19) (20) . Surprisingly, the site of interaction with AKAP15 and PKA is located beyond the point of truncation in the C terminus (9) . Because PKA anchored at this site is required for effective regulation of skeletal muscle Ca 2ϩ channels by voltage-dependent potentiation and PKA, these results raise the possibility that the proteolytically cleaved distal C terminus remains associated with the remainder of the skeletal muscle Ca 2ϩ channel to allow this regulation to occur. In the experiments reported here, we have demonstrated that the distal C terminus associates with the remainder of the channel when coexpressed as a separate protein in nonmuscle cells, mapped the site of interaction between the distal and proximal Cterminal domains, and defined the point of proteolytic truncation of the Ca V 1.1 channel precisely by mass spectrometric analysis. Our results provide biochemical evidence for the formation of a specific complex of the ␣ 1 -subunit of the Ca V 1.1 channel truncated at alanine 1664 with its distal cleaved Cterminal peptide beginning at asparagine 1665, which has specifically bound AKAP15 and PKA.
Experimental Procedures
Antibodies, Peptides, and cDNA Constructs. Rabbit polyclonal anti-CP1 and anti-CP11 antibodies were generated against peptides corresponding to residues (1857-1873) and (1601-1618) of the rabbit skeletal muscle ␣ 1 sequence (21) and characterized as described (14) . Monoclonal anti-myc antibody was purchased from Invitrogen. Ca V 1.1 ⌬1684 was constructed by amplifying a BamHI͞NotI fragment with primers incorporating a stop codon after position 1684 and subcloning the truncated fragment into ␣1.1 pCDNA3. Ca V 1.1 1685-1873 was amplified by PCR using specific primers and cloned in-frame into pCDNA3mycHisA (Invitrogen). Sequences corresponding to the proximal Cterminal fragments (1382-1698, 1382-1556, 1518-1698, 1518-1572, 1556-1612, and 1606-1656) of the ␣ 1 -subunit of the rabbit skeletal Ca 2ϩ channel were amplified by PCR and cloned in frame into the Gal4 DNA binding domain vector, pAS2-1 (Clontech). Distal C-terminal constructs (1753-1873, 1774-1841, and 1802-1841) were generated in the same manner and cloned in-frame into the Gal4 activation domain vector, pACT2 (Clontech). N-terminally acylated C-terminal fragments of Ca V 1.1 were constructed by incorporating the sequence (MGQLCC) that directs N-terminal myristoylation and palmitoylation of AKAP15 onto the N terminus of the C-terminal fragments by PCR and cloned in-frame into pcDNA3mycHisA (Invitrogen). The orientation and reading frame of all constructs were confirmed by DNA sequencing.
Coimmunoprecipitation Experiments. TsA-201cells were cultured in DMEM F12 supplemented with 10% FBS and 100 units͞ml penicillin and streptomycin and plated on 15-cm dishes. Cells were transfected with 50 g of an equimolar ratio of expression plasmid cDNA using the calcium phosphate method. Forty-eight hours after transfection, cells were washed in PBS, solubilized in ice-cold bRIA (50 mM Tris⅐HCl, pH 7.4͞150 mM NaCl͞1 mg⅐ml Ϫ1 BSA͞50 mM NaF͞5 mM EGTA͞5 mM EDTA͞1% Triton X-100, plus protease inhibitors) and rotated at 4°C for 30 min. Unsolubilized material was removed by centrifugation, and lysates were precleared with protein A Sepharose. Precleared lysates were incubated with 10 g of anti-CP11, anti-CP1, or control nonimmune IgG for 2 h at 4°C, followed by the addition of protein A Sepharose (50 l) for an additional 2 h. Immune complexes bound to the Sepharose beads were washed extensively, and proteins were separated by SDS͞PAGE, transferred to nitrocellulose, and analyzed by immunoblotting. Ca V 1.1 ⌬1684 was detected by anti-CP11. Ca V 1.1 1685-1873 and the Myc-tagged N-acyl C-terminal fragments were detected by using monoclonal anti-myc antibody. Each immunoprecipitation experiment was repeated at least three times.
Yeast Two-Hybrid Assay. cDNAs encoding different regions of the proximal and distal C terminus of Ca V 1.1 were cotransformed into the Y190 yeast strain, containing two Gal4-inducible reporter genes, HIS3 and LacZ, by using the TRAFCO LiAc method. Cotransformants were first plated onto synthetic dropout medium lacking tryptophan and leucine (trp Ϫ leu Ϫ ) to select for colonies containing both hybrid plasmids and then transferred onto medium that also lacked histidine (trp Ϫ leu Ϫ his Ϫ ) to select for protein-protein interactions. The media was supplemented with 30 mM 3-amino-1,2,4-triazole to suppress background growth of the Y190 yeast strain. Only those transformants that grew on trp Ϫ leu Ϫ his Ϫ media at 30°C were assayed for ␤-galactosidase activity by using the colony filter lift assay. Data shown are representative of at least four separate experiments.
Purification and Mass Spectrometric Analysis of Skeletal Muscle
CaV1.1 Channels. [ 3 H]PN200-110, endoproteinase Asp-N and endoproteinase Glu-C were purchased from Roche Applied Sciences. Trypsin Gold, Mass Spectrometry Grade, was from Promega. Wheat germ agglutinin (WGA)-Sepharose and Nacetylglucosamine were from Sigma. CNBr-Activated Sepharose 4B and DEAE Sephadex A-25 were obtained from Amersham Pharmacia. Skeletal muscle Ca V 1.1 channels were purified by chromatography on WGA-Sepharose and DEAE ion exchange chromatography (22) from rabbit skeletal muscle transverse tubule membranes prepared according to Florio et al. (23) . All buffers contained 35 g͞ml phenylmethanesulfonyl fluoride, 0.5 g͞ml leupeptin, 0.7 g͞ml pepstatin A, 1 g͞ml aprotinin, and 200 g͞ml o-phenanthroline. The purity and quantity of the Ca V 1.1 channel preparation were analyzed by SDS͞PAGE and Coomassie Blue staining, and the moles of purified Ca 2ϩ channel were estimated assuming a molecular mass of 429 kDa for the channel complex. The ␣ 1 -subunit band was excised from the gel and subjected to ''in-gel'' proteolysis with three different proteases: trypsin to cleave at the carboxyl side of lysine and arginine residues; Asp-N to cleave at the amino side of asparagine residues; and Glu-C to cleave at the carboxyl side of glutamate residues. In-gel digested peptide samples were cleaned before tandem mass spectrometry (MS͞MS) analyses by application to 1-ml SPE C18 columns (Discovery DSC-18, Supelco, Bellefonte, PA) and eluted with 80% acetonitrile͞0.1% trifluoroacetic acid. The eluted peptides were concentrated by using a Speed-Vac SC 250 Express (ThermoSavant, Holbrook, NY). BCA protein assays were performed to determine the final peptide concentrations, and samples were snap frozen and stored at Ϫ80°C. The peptides were analyzed by high-resolution reversed-phase capillary liquid chromatography coupled to an electrospray ionization interface with a ThermoFinnigan LCQ ion trap mass spectrometer (ThermoFinnigan, San Jose, CA) to perform MS͞MS measurements as described (24) . To enhance detection of short peptides down to Ϸ7 amino acid residues in length, analyses employing narrow segmented mass ranges (m͞z windows) were performed. SEQUEST (ThermoFinnigan) matching analysis of the MS͞MS spectra was performed against the NCBI Oryctolagus cuniculus (rabbit) protein FASTA database (6,110 proteins) applying stringent filtering guidelines. Using an approach similar to that described by Qian et al. (25) , confident tryptic peptide identifications were obtained by the application of the following scoring criteria: (i) SEQUEST DelCN value of Ն0.10 and (ii) SEQUEST XCorr (correlation score) Ն1.5 for charge state 1ϩ and full tryptic peptides, Ն3.1 for partial tryptic peptides; Ն1.9 for charge state 2ϩ and full tryptic peptides, Ն3.8 for partial tryptic; and Ն2.9 for charge state 3ϩ and full tryptic peptides, Ն4.5 for partial tryptic peptides. Confident peptide identifications for Asp-N and Glu-C protease digests were obtained by applying the following scoring criteria: (i) SEQUEST DelCN value Ն0.05 and (ii) SEQUEST XCorr Ն1.8 for charge state 1ϩ; Ն1.9 for charge state 2ϩ; and Ն3.75 for charge state 3ϩ.
Results and Discussion
Association of the Distal C Terminus with the Cleaved CaV1.1 Channel.
Expression of Ca V 1.1 channels by transfection of full-length cDNA in tsA-201 cells yields only full-length ␣ 1 -subunit proteins, as detected by anti-peptide antibodies against the final Cterminal peptide (Fig. 1A) . This finding is in marked contrast to skeletal muscle, where C-terminal truncated ␣ 1 -subunit proteins are the predominant form (14) . These results suggest that the proteolytic enzyme necessary for processing Ca V 1 channels is not present in these nonmuscle cells. To examine the association of the cleaved distal C terminus with the remainder of the Ca V 1.1 channel, we expressed the distal C terminus in tsA-201 cells as a separate protein, consisting of amino acid residues 1685-1873 and a C-terminal myc epitope tag, in combination with the remainder of the Ca V 1.1 channel (amino acid residues 1-1684; Fig. 1B ). Analysis of cell lysates by immunoblotting revealed robust expression of both proteins (Fig. 1C, lane 1) . Immunoprecipitation of the Ca V 1.1⌬1684 ␣ 1 -subunit with anti-CP11 antibodies resulted in coimmunoprecipitation of the distal C terminus as detected with antibodies against the myc epitope (Fig. 1C Lower, lane 2) . No coimmunoprecipitation was observed with nonimmune IgG (Fig. 1C Lower, lane 3) . These results demonstrate formation of a specific complex between the cleaved distal C-terminal domain of Ca V 1.1 and the remainder of the channel protein when expressed in nonmuscle cells.
Specific Association of Peptides from the Distal and Proximal C-
Terminal Domains in Mammalian Cells. We hypothesized that the distal C terminus may remain in noncovalent association with the proximal C terminus after proteolytic cleavage in vivo. To examine the interaction between the proximal and distal Cterminal domains in intact cells, immunoprecipitation experiments were performed in the tsA-201 line of human embryonic kidney cells. The N-terminal acylation sequence of AKAP15 was engineered onto the N terminus of the distal and proximal Ca V 1.1 C-terminal fusion proteins to target them to the plasma membrane as described (9) . Cell lysates were immunoprecipitated with anti-CP1 to immunoprecipitate Ca V 1.1 1753-1873 or control IgG, and the immunoprecipitated Ca V 1.1 1518-1698 protein was detected with anti-CP11. Immunoblotting of cell lysates with anti-CP11 or anti-CP1 demonstrated robust expression of the Ca V 1.1 1518-1698 and Ca V 1.1 1753-1873 proteins, respectively (Fig. 2, lane 1) . Ca V 1.1 1518-1698 specifically coimmunoprecipitated with Ca V 1.1 1753-1873 (Fig. 2B Upper,  lane 3) but not control IgG (Fig. 2B Upper, lane 2) . These results demonstrate that the proximal C-terminal domain directly binds to the distal C-terminal domain through noncovalent proteinprotein interactions. To define the points of interaction between the distal and proximal C-terminal domains, we used the yeast two-hybrid assay. We found that a full-length proximal C-terminal peptide consisting of amino acid residues 1382-1698 interacted effectively with a distal Cterminal peptide consisting of amino acid residues 1753-1873 to reconstitute an active gal-4 transcription factor and allow transcription of nutritional markers in intact yeast cells (Fig. 3) . Analysis of the interactions of five deletion constructs revealed that a peptide consisting of amino acid residues 1556-1612 was sufficient to interact with the distal C terminus (1753-1873; Fig.  3 ). Thus, this 56-aa segment of the proximal C terminus is likely to form an interaction site for the distal C terminus.
Mapping the Interaction Site for the Proximal C Terminus Within the
Distal C Terminus of the CaV1.1 ␣1-Subunit. We performed a complementary set of analyses using the yeast two-hybrid system to identify the amino acid sequence in the distal C terminus that is responsible for its interaction with the proximal C terminus (Fig.  4) . Analysis of three deletion constructs showed that a peptide consisting of amino acid residues 1802-1841 in the distal C terminus was sufficient to interact with the proximal C-terminal interaction domain (PCID, residues 1556-1612; Fig. 4 ). Taken together, these data suggest that this 39-amino-acid-residue peptide forms a distal C-terminal interaction domain (DCID) for binding of the distal C terminus to the PCID.
Identification of the C-Terminal Amino Acid Residue of the ␣1-Subunit
of CaV1.1 Channels. Our results defining the sites of specific interaction of the cleaved distal C terminus with the proximal C-terminal domain of Ca V 1.1 emphasize the importance of identifying the precise point of proteolytic truncation of Ca V 1.1 to fully characterize the molecular properties of the components of this complex. In previous studies, we mapped the C terminus of the ␣ 1 -subunit of Ca V 1.1 channels by using an overlapping series of anti-peptide antibodies and concluded that it was near amino acid residues 1685-1699 (14) . The development of highresolution mass spectrometry techniques now allows precise determination of the C-terminal amino acid residue by a saturation sequencing strategy in which the hydrophilic peptides in the intracellular domains of the ␣ 1 -subunit are identified and sequenced as completely as possible. We purified the Ca V 1.1 channel from rabbit skeletal muscle and isolated the ␣ 1 -subunit by SDS-PAGE as described in Experimental Procedures (Fig. 5A) . The ␣ 1 -subunit band was excised from the gel and subjected to in-gel proteolysis with three different proteases: trypsin to cleave at the carboxyl side of lysine and arginine residues; Asp-N to cleave at the amino side of asparagine residues; and Glu-C to cleave at the carboxyl side of glutamate residues. The resulting peptides were analyzed by MS͞MS combined with highresolution liquid chromatography methods that led to confident identification of peptides as small as seven amino acid residues in length. In this analysis, all internal peptides should end in the amino acid residue characteristic of the protease used for cleavage in vitro, except for the C-terminal peptide, which should end in its natural terminal amino acid residue when cleaved with all three proteases.
As illustrated in Fig. 5B , we achieved near-saturation sequencing of the proteolytic peptides derived from the N and C termini and the large hydrophilic intracellular loops of the Ca V 1.1 channel up to residue 1664 in the C-terminal domain (see Table  1 , which is published as supporting information on the PNAS web site). In the C-terminal domain, nearly all peptides up to position 1664 were identified that had predicted length Ͼ6 aa after cleavage with one of the three proteases (Fig. 5C ). In the analysis of tryptic peptides, the final peptide ended at arginine 1652, a residue expected from tryptic cleavage. In contrast, the final Asp-N peptide ended at alanine 1664 (A1664), an amino acid residue not expected from Asp-N cleavage. Similarly, the final Glu-C peptide also ended at A1664, which is not expected from Glu-C cleavage (Fig. 5C) . These results implicate A1664 as the final amino acid residue in the in vivo truncated form of Ca V 1.1. The results of the tryptic peptide analysis are also consistent with this conclusion because the final predicted peptide from tryptic cleavage would be the hexapeptide A1659-A1664, which would not be readily detected because it is Ͻ7 aa.
Conserved Amino Acid Sequences of CaV1.1 and CaV1.2 Channels at the

Sites of C-Terminal Interaction and Proteolytic Cleavage.
It is interesting to compare the amino acid sequences of the Ca V 1 family of channels in the sites of interaction between the proximal and distal C-terminal domains and in the region surrounding the site of proteolytic cleavage (Fig. 6) , because both Ca V 1.1 and Ca V 1.2 channels are subject to in vivo proteolytic processing (14, 19, 20, 26). Alignment of the C-terminal domains of Ca V 1.1 and Ca V 1.2 channels shows striking conservation of the amino acid sequences in the PCID, the AKAP15-binding domain (ABD), and DCID (Fig. 6 ) compared to the poorly conserved amino acid sequences between them. Interestingly, the ABD and DCID are immediately adjacent in the distal C terminus. Similarly, comparison of the aligned amino acid sequences around the site of proteolytic cleavage also reveals striking conservation of amino acid sequence (Fig. 6 ). In fact, this sequence was proposed as a possible site of proteolytic recognition or functional regulation based on its high conservation of amino acid sequence in our previous antibody-mapping studies (14) . The high level of amino acid sequence conservation is consistent with the conclusions that both Ca V 1.1 and Ca V 1.2 channels are cleaved at the equivalent of A1664 in vivo and that the resulting distal Cterminal domain remains associated with the remainder of the channels through noncovalent interactions of analogous sites in the proximal and distal C-terminal domains.
Comparison of the amino acid sequences of Ca V 1.3 and Ca V 1.4 channels with the PCID, proteolytic cleavage site, ABD, and DCID from Ca V 1.1 channels reveals an interesting dichotomy. The amino acid sequence of Ca V 1.3 channels is well conserved at all four of these sites (Fig. 6) . Therefore, it is likely that this channel is also proteolytically processed, its distal C-terminal domain remains associated with the channel through interactions of its DCID and PCID, and a complex of PKA and AKAP15 binds to the ABD and regulates channel function. In marked contrast, the ABD of Ca V 1.4 channels is well conserved, especially the heptad repeat of hydrophobic residues that binds AKAP15 via a modified leucine zipper, but the proteolytic cleavage site is not well conserved. This striking difference in amino acid sequence raises the interesting possibility that Ca V 1.4 channels are not proteolytically processed so that the distal C-terminal domain is not required to associate noncovalently with the proximal C-terminal domain. Nevertheless, Ca V 1.4 channels, which are highly expressed in the retina, may be regulated by PKA specifically targeted to them through interaction with AKAP15 bound to the conserved ABD.
Possible Mechanism of Proteolytic Cleavage. Indirect evidence suggests that a calpain-like protease may be responsible for in vivo proteolytic cleavage of Ca V 1 channels. The C-terminal domain of Ca V 1.2 channels in brain is truncated (26) . In intact hippocampal neurons in brain slices, regulated proteolytic cleavage of the C terminus of Ca V 1.2 channels is induced by Ca 2ϩ influx through NMDA-activated glutamate receptors, and proteolytic cleavage of ␣ 1 1.2 in these intact cells can be prevented by calpain inhibitors (27) . Purified calpain 1 can cleave the C-terminal domain of purified Ca V 1.1 channels in vitro, but the site of cleavage is not identical to the in vivo site based on SDS͞PAGE analysis (28) . Cleavage at A1664 is also consistent with the catalytic specificity of calpain proteases (29) . Moreover, a conserved PEST sequence rich in proline, glutamate, serine, and threonine is located Ϸ27 aa upstream of A1664 (PEST, Fig. 6 ) in position to serve as a substrate recognition site for calpains (30) . Further experiments with specific members of the family of 12 calpain isozymes are needed to confirm that a calpain protease is indeed involved in the in vivo proteolytic processing of this family of Ca 2ϩ channels.
Potential Physiological Significance of Proteolytic Processing. The conserved proteolytic processing of Ca V 1.1 and Ca V 1.2 channels suggests that this cleavage has physiological significance. What physiological role might be served by this proteolytic processing event? Expression of Ca V 1.1 and Ca V 1.2 channels with truncated C termini in Xenopus oocytes or tsA-201 cells increases the functional activity of these channels (31) (32) (33) (34) , suggesting that the distal C terminus has an autoinhibitory effect. Short peptides derived from the distal C-terminal domain inhibit Ca V 1.2 channels (33) . Moreover, coexpression of the distal C-terminal domain as a separate protein with the remainder of Ca V 1.2 channels in tsA-201 cells gives potent inhibition, decreasing channel activity below the level of the full-length ␣ 1 -subunit. ʈ In light of these results with Ca V 1.2 channels, the cleaved distal C-terminal domain of Ca V 1.1 channels may also serve an autoinhibitory function. In skeletal muscle cells, the level of Ca 2ϩ channel ion conductance activity is low compared to the large number of Ca V 1.1 channels present (3, 34) , and the principal function of the Ca V 1.1 channel is voltage-dependent activation of the ryanodine-sensitive sarcoplasmic reticulum Ca 2ϩ channel, which releases Ca 2ϩ into the cytosol to initiate contraction (1) . Inhibition of Ca 2ϩ conductance by the cleaved, noncovalently associated C-terminal autoinhibitory domain may serve to reduce unwanted Ca 2ϩ entry through Ca V 1.1 channels unless that inhibition is relieved by cAMP-dependent phosphorylation. Consistent with that idea, disruption of the leucine zipper interaction between AKAP15 and the distal C terminus of Ca V 1.1 is effective in blocking voltage-dependent potentiation, which depends on PKA activity (4, 6, 9) . Evidently, a noncovalent complex composed of Ca V 1.1 channels truncated at A1664, the cleaved distal C-terminal domain, AKAP15, and PKA is likely to be the primary physiological form of Ca V 1.1 channels in skeletal muscle cells. Recent studies indicate that Ca 2ϩ channel regulation is impaired in dystrophic mouse muscle cells (35) , suggesting that dysfunction of this signaling complex may be important in neuromuscular disease.
